U.S. markets open in 37 minutes
  • S&P Futures

    3,788.25
    +22.75 (+0.60%)
     
  • Dow Futures

    31,094.00
    +216.00 (+0.70%)
     
  • Nasdaq Futures

    12,492.00
    +37.00 (+0.30%)
     
  • Russell 2000 Futures

    2,171.30
    +26.80 (+1.25%)
     
  • Crude Oil

    65.35
    +1.52 (+2.38%)
     
  • Gold

    1,693.30
    -7.40 (-0.44%)
     
  • Silver

    25.15
    -0.32 (-1.24%)
     
  • EUR/USD

    1.1922
    -0.0057 (-0.48%)
     
  • 10-Yr Bond

    1.6190
    +0.0690 (+4.45%)
     
  • Vix

    27.88
    +1.21 (+4.54%)
     
  • GBP/USD

    1.3814
    -0.0080 (-0.57%)
     
  • USD/JPY

    108.4720
    +0.4960 (+0.46%)
     
  • BTC-USD

    48,253.12
    -1,113.58 (-2.26%)
     
  • CMC Crypto 200

    964.05
    -23.16 (-2.35%)
     
  • FTSE 100

    6,665.55
    +14.67 (+0.22%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

Brooks to Participate in Upcoming Virtual Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

CHELMSFORD, Mass., Nov. 24, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in two upcoming virtual investor conferences:

  • Credit Suisse 24th Annual Virtual Technology Conference on December 1, 2020 with a 30-minute webcast beginning at 4:10 p.m. ET

  • Wells Fargo Virtual TMT Summit 2020 on December 2, 2020 with a 30-minute webcast beginning at 12:40 p.m. ET

The live audio webcasts can be accessed through the Investor Relations page of the Brooks Automation website https://brooks.investorroom.com/events. A replay of the presentations will be available following the events.

About Brooks Automation
Brooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com.

INVESTOR CONTACTS:

Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com

Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com

(PRNewsfoto/Brooks Automation)
(PRNewsfoto/Brooks Automation)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/brooks-to-participate-in-upcoming-virtual-investor-conferences-301180034.html

SOURCE Brooks Automation